增生性瘢痕色素异常的信号通路分子病理研究
本研究在杜洛克猪全层创面愈合形成的色素异常增生性瘢痕中,通过活检和原代细胞培养研究色素信号。两种色素区域均存在黑素细胞,低色素区P53表达无差异,高色素区POMC、ACTH、α-MSH、SCF、c-KIT和MC1R上调,TYR、TYRP1、DCT在完整活检中上调。
要点
- 低色素瘢痕中仍存在黑素细胞,经qRT-PCR和原代培养证实。
- 高色素区POMC、ACTH、α-MSH、SCF、c-KIT、MC1R表达上调。
- TYR、TYRP1、DCT在高色素区完整活检中上调,MiTF表达无差异。
核心结论
- 增生性瘢痕色素异常涉及黑素细胞存在及多条信号通路差异表达。
研究设计与样本
- 杜洛克猪全层创面愈合形成色素异常增生性瘢痕,取活检和原代细胞培养研究色素信号。
主要发现
- 异质性色素异常瘢痕形成高色素区和低色素区。
- S100β qRT-PCR和免疫染色显示两种色素区均存在黑素细胞。
- 高色素区POMC、ACTH、α-MSH、SCF、c-KIT和MC1R较低色素区上调。
- 微阵列分析显示MITF、TYR、TYRP1、DCT等基因差异调控。
- TYR、TYRP1、DCT在高色素区完整活检中qRT-PCR和免疫染色证实上调,MiTF表达无差异。
临床怎么用
- 了解色素异常信号初始步骤及下游效应有助于指导瘢痕治疗和药物靶点选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hypertrophic scar (HTS) occurs frequently after burn injury. Treatments for some aspects of scar morbidity exist, however, dyspigmentation treatments are lacking due to limited knowledge about why scars display dyschromic phenotypes. Full thickness wounds were created on duroc pigs that healed to form dyschromic HTS. HTS biopsies and primary cell cultures were then used to study pigmentation signaling. Biopsies of areas of both pigment types were taken for analysis. At the end of the experiment, melanocyte-keratinocyte cocultures were established from areas of differential pigmentation. Heterogeneously dyspigmented scars formed with regions of hyperpigmentation and hypopigmentation. Melanocytes were present in both pigment types measured by S100β quantitative real time-polymerase chain reaction (qRT-PCR) and immunostaining, and visualized by dendritic cell presence in primary cultures. P53 expression was not different between the two pigment types. Hyperpigmented scars had upregulated levels of proopiomelanocortin (POMC), adrenocorticotropic hormone (ACTH), α-melanocyte stimulating hormone (α-MSH), stem cell factor (SCF), and c-KIT and melanocortin 1 receptors (MC1R) compared to hypopigmented regions. Many genes involved in dyspigmentation were differentially regulated by microarray analysis including MITF, TYR, TYRP1, and DCT. MiTF expression was not different upon further exploration, but TYR, TYRP1, and DCT were upregulated in intact biopsies measured by qRT-PCR and confirmed by immunostaining. This is the first work to confirm the presence of melanocytes in hypopigmented scar using qRT-PCR and primary cell culture. An understanding of the initial steps in dyspigmentation signaling, as well as the downstream effects of these signals, will inform treatment options for patients with scars and provide insight to where pharmacotherapy may be directed.
引用
- Carney BC, Chen JH, Luker JN, et al. Pigmentation Diathesis of Hypertrophic Scar: An Examination of Known Signaling Pathways to Elucidate the Molecular Pathophysiology of Injury-Related Dyschromia. J Burn Care Res. 2019. PMID: 30189005. doi:10.1093/jbcr/iry045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。